drugset / Trial / NCT04999449
Nebulizer Delivery of Intranasal Scopolamine
RandomizedParallel-groupOpen-labelTreatment
Summary
To develop a better way to administer anti-motion sickness medications using an intranasal nebulizer.
Timeline
- Start
- 2022-01-24
- Primary completion
- 2025-05-07
- Completion
- 2025-05-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Scopolamine | Unknown | 0.2 mg | Intranasal |
| Subject | Scopolamine | Unknown | 0.4 mg | Intranasal |